| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,254 |
18,106 |
$1.31M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,246 |
3,056 |
$306K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,425 |
2,382 |
$200K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,992 |
8,586 |
$196K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,115 |
2,031 |
$154K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,673 |
1,634 |
$138K |
| 92587 |
|
4,491 |
4,029 |
$62K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
591 |
544 |
$49K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,393 |
5,162 |
$40K |
| 90461 |
|
2,691 |
2,578 |
$38K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
813 |
788 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
545 |
490 |
$24K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
7,877 |
7,070 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
996 |
949 |
$23K |
| 90671 |
|
234 |
209 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,615 |
1,517 |
$18K |
| 99177 |
|
1,993 |
1,913 |
$8K |
| 90686 |
|
2,414 |
1,941 |
$8K |
| 90670 |
|
623 |
463 |
$8K |
| 0072A |
|
150 |
146 |
$6K |
| 36410 |
|
450 |
437 |
$5K |
| 0071A |
|
114 |
114 |
$5K |
| 90723 |
|
459 |
430 |
$3K |
| 99381 |
|
39 |
36 |
$3K |
| 92558 |
|
468 |
417 |
$3K |
| 99188 |
|
110 |
110 |
$2K |
| 96161 |
|
1,664 |
1,499 |
$2K |
| 90716 |
|
160 |
113 |
$2K |
| 90633 |
|
512 |
387 |
$2K |
| 90707 |
|
264 |
196 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
135 |
121 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$1K |
| 90651 |
|
53 |
46 |
$1K |
| 90681 |
|
435 |
279 |
$1K |
| 90648 |
|
1,264 |
867 |
$946.97 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
58 |
54 |
$926.14 |
| 90685 |
|
137 |
135 |
$843.05 |
| 90734 |
|
31 |
26 |
$638.01 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
14 |
14 |
$628.97 |
| 36406 |
|
46 |
45 |
$567.88 |
| 0001A |
|
14 |
14 |
$560.00 |
| 0011A |
|
14 |
14 |
$560.00 |
| 99051 |
|
858 |
831 |
$548.12 |
| 83655 |
|
230 |
191 |
$405.39 |
| 92567 |
|
29 |
28 |
$354.13 |
| 36415 |
Collection of venous blood by venipuncture |
114 |
113 |
$276.89 |
| 99000 |
|
2,306 |
2,230 |
$186.85 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19 |
17 |
$144.71 |
| A7015 |
Aerosol mask, used with dme nebulizer |
121 |
108 |
$112.52 |
| 86580 |
|
12 |
12 |
$74.32 |
| 91307 |
|
260 |
243 |
$66.00 |
| 87807 |
|
23 |
18 |
$57.12 |
| 91300 |
|
43 |
41 |
$18.00 |
| 36416 |
|
62 |
60 |
$12.60 |
| 91305 |
|
35 |
29 |
$8.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
94 |
76 |
$4.20 |
| 91301 |
|
14 |
14 |
$4.00 |
| 99072 |
|
480 |
469 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
12 |
$0.00 |